跳至主要内容
临床试验/ACTRN12614000215628
ACTRN12614000215628招募中3 期

A study evaluating the efficacy and safety of artesunate for the treatment of uncomplicated plasmodium falciparum malaria in Pa-An (Mon State) in Myanmar

Clinical Research Unit ( Malaria), Defense Services General Hospital0 个研究点目标入组 50 人开始时间: 2014年2月28日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • male and female age older than 18 years; mono-infection with P. falciparum detected by microscopy (parasitaemia of 10 000-100 000/microlitres asexual forms or P. vivax detected by microscopy (parasitaemia greater than 250/microlitres asexual forms); presence of axillary greater than or equal to 37.5 degrees celcius or history of fever during the past 24 h; ability to swallow oral medication; ability and willingness to comply with the study protocol for the duration of the study and to comply with the study visit schedule; and informed consent from the patient

排除标准

  • Presence of signs of severe falciparum malaria according to the definitions of WHO; mixed or mono-infection with another Plasmodium species detected by microscopy; presence of febrile conditions due to diseases other than malaria (e.g. acute lower respiratory tract infection, severe diarrhoea with dehydration) or other known underlying chronic or severe diseases (e.g. cardiac, renal and hepatic diseases, HIV/AIDS); regular medication, which may interfere with antimalarial pharmacokinetics; history of hypersensitivity reactions or contraindications to any of the medicine(s) being tested or used as alternative treatment(s); and a positive pregnancy test or breastfeeding unable to or unwilling to take a pregnancy test or contraceptives (for women of child-bearing age);patients presenting with splenectomy.

研究者

发起方
Clinical Research Unit ( Malaria), Defense Services General Hospital

相似试验

招募中
3 期
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine phosphate for the treatment of uncomplicated Plasmodium falciparum malaria, and chloroquine for Plasmodium vivax in Ta Beik Kyin Township, Mandalay Region and dihydroartemisinin-piperaquine phosphate for the treatment of uncomplicated Plasmodium falciparum malaria in Ta-mu township, Sagaing RegioInfection - Other infectious diseasesMalaria
ACTRN12614000216617Department of Medical Research (Upper Myanmar)160
招募中
3 期
Efficacy and safety of artemether-lumefantrine (AL) combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in 4 sites in India Annuppur district, Madhya Pradesh, Jhabua district, Madhya Pradesh, Bastar district, Chhattisgarh and Palamudistrict, JharkhandInfection - Other infectious diseasesMalaria
ACTRN12614000765628Indian Council of Medical Research, Ministry of Health & Family welfare352
招募中
3 期
Monitoring the therapeutic efficacy of antimalarial medicines across International borders of India.Infection - Other infectious diseasesMalaria
ACTRN12614000217606ational Insititute of Malaria Research70
尚未招募
3 期
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Kobeni site (provide of Hodh El Gharbi) and Timbedra (Hodgh Echargui province), MauritaniaInfection - Other infectious diseasesMalaria
ACTRN12614001107617Ministry of Health120
招募中
4 期
The study to evaluate the efficacy and safety of Adjustable-depth fractional microneedle bipolar radiofrequency in Treatment of Wrinkle and Neck ContouringHealthy PatientAdjustable-depth fractional microneedle bipolar radiofrequency,Wrinkle and Neck Contouring
TCTR20230403002ASTRACO MEDICAL NETWORKS LTD.27